Tag Archive for: glp-1

GLP-1 Skin Is Real — Here’s How Dermatologists Are Treating It

/in , /by

Rapid weight loss can transform your health, energy, and metabolic markers. But for many people taking GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Zepbound, there’s an unexpected side effect that often shows up in the mirror first: thinner, drier, more hollow-looking skin.

Dermatologists are increasingly referring to this as “GLP-1 skin” — a combination of volume loss, skin laxity, dehydration, and accelerated collagen decline that can happen after significant medication-driven weight loss.

Now, emerging research suggests that regenerative treatments may help address these changes more effectively than traditional fillers alone. A recent study conducted by Dr. Andreas Nikolis[1] examined how combining Sculptra and Restylane Skinboosters improved hydration, skin barrier function, elasticity, and collagen support in menopausal women — and researchers also explored how GLP-1 medications may alter fat tissue itself.

Why GLP-1 Skin Happens

Most people assume the issue is simply “losing fat in the face.” But researchers are beginning to think the biology is more complicated. In interim data presented this spring, investigators found that patients experiencing medication-driven weight loss showed a significant reduction in adipose-derived stem cells — cells involved in tissue regeneration and structural support.[2]

That may help explain why some people notice: hollow cheeks and temples, crepey or loose skin, increased dryness, more visible wrinkles, sagging around the jawline, and skin that suddenly looks “tired” or deflated. The changes can resemble what happens during menopause, when estrogen decline contributes to rapid collagen loss, thinning skin, and impaired barrier function.

The New Approach: Hydration + Collagen Stimulation

For years, aesthetic medicine focused heavily on replacing lost volume with filler. But many dermatologists now believe GLP-1 skin requires a broader regenerative approach. That’s where treatments like Restylane Skinboosters and Sculptra come in.

Restylane Skinboosters: Rehydrating the Skin

Restylane Skinboosters use hyaluronic acid to improve hydration, smoothness, and skin quality rather than creating dramatic volume. Think of it as improving the condition of the skin itself instead of simply “filling” it. In the recent menopause-focused trial, patients who received Restylane Skinboosters first experienced the greatest improvement in hydration and barrier function. For GLP-1 patients, that matters because rapid weight loss often leaves skin looking dehydrated and fragile before volume loss becomes severe.

Sculptra: Rebuilding Collagen Over Time

Sculptra works differently from traditional fillers. Instead of instantly filling space, it stimulates the body to gradually produce collagen over several months. That slow collagen remodeling may be particularly useful for people experiencing diffuse facial thinning, crepey texture, skin laxity, and structural collagen decline.

Researchers noted that regenerative treatments like Sculptra may align better with the biology of medication-driven weight loss because the issue may involve tissue regeneration — not just fat depletion.

Why Combination Treatment Matters

One of the most interesting findings from the new data is that sequencing appears important. The combination approach worked best when hydration was restored first, followed by collagen stimulation later. That mirrors what many cosmetic dermatologists already see clinically: rehydrate the skin; improve barrier function; stimulate collagen gradually; and restore structure conservatively. This tends to create more natural-looking results than aggressively adding filler to an already dehydrated face.

Other Treatments That May Help GLP-1 Skin

Injectables are only part of the picture. Dermatologists often combine them with treatments that support collagen production and skin quality. Common options include:

Microneedling

Creates controlled micro-injury that stimulates collagen remodeling.

Radiofrequency Microneedling

Combines collagen induction with skin tightening.

Prescription Retinoids

Tretinoin remains one of the most evidence-based topical collagen stimulators available.

Growth Factor or Peptide Skincare

Some patients use regenerative skincare products to support healing and elasticity.

Hormonal Evaluation

For peri- and postmenopausal women, hormonal shifts may compound GLP-1-related collagen loss. Some patients report improved skin quality after starting hormone replacement therapy, although treatment should always be individualized medically.

What Dermatologists Want Patients to Understand

The biggest misconception about GLP-1 skin is that more filler is automatically the answer.

In reality, overfilling can sometimes worsen the problem by making the face appear puffy while skin quality remains thin and dehydrated. The goal is not to erase weight loss — it’s to help the skin adapt to it. Many experts now favor a regenerative strategy focused on collagen support, hydration, gradual restoration, and skin health first.

The Bottom Line

GLP-1 medications are changing medicine and helping millions improve their health. But rapid weight loss can expose underlying collagen loss, skin thinning, and structural changes faster than the skin can naturally recover. Emerging research suggests the future of treatment may combine: hydration-focused injectables like Restylane Skinboosters; regenerative collagen stimulators like Sculptra; energy-based tightening treatments; medical-grade skincare; individualized hormonal and nutritional support; and, more importantly, dermatologists are beginning to treat GLP-1 skin as a biologic process — not just a cosmetic concern.

 

 

 

Sources

[1] Nikolis A, et al. A comprehensive interim analysis of skin hydration, barrier function (TEWL), elasticity, and patient satisfaction across two treatment arms. Interim Data on File. Galderma. April 2026

[2]  Fabi S, et al. Investigating the Impact of GLP-1 Receptor Agonists on Adipose-Derived Stem Cells. Interim Data on File. Galderma. April 2026

Galderma

Interim data from two ongoing investigator-initiated trials highlight the role of Sculptra® and Restylane® in addressing aesthetic changes associated with weight loss medications and menopause | Galderma. April 8, 2026

Dermatology Times

Galderma Unveils New Interim Trial Data on Menopause and Weight Loss-Driven Skin Changes | Dermatology Times

reachmd.com

Interim IIT Data Explore Sculptra, Restylane for Menopause, Weight Loss–Related Aesthetic Changes – Be part of the knowledge – ReachMD

CenterWatch

Post-Menopause Skin Rejuvenation Study | Clinical Research Trial Listing. January 19, 2026

ICHGCP

Sculptra Aesthetic and Restylane SkinBoosters Vital in Menopause and Post-menopause and Hyaluronic Acid – Clinical Trials Registry – ICH GCP

MedEsthetics

New Dual-Sequence Menopause Study Shows Skin Quality Improvement With Restylane Skinboosters and Sculptra | MedEsthetics. April 12, 2026

What is Ozempic Face and What Can You do About It?

/in , /by

By Elena Allbritton, MD

With over 2.3 million views of #ozempicface on TikTok and social media abuzz with stories about “Ozempic face,” numerous articles have been written about the facial changes following rapid and substantial weight loss. The phrase was coined by NY dermatologist Dr. Paul Frank, who observed his patients on weight-loss medications complaining about their gaunt, sagging faces. Although linked with Ozempic, a prescription drug developed to treat diabetes, the real culprit behind “Ozempic Face” is significant weight loss. So is the trade-off for dramatic weight loss a wrinkled, older-appearing face? The short answer is yes, although some people are more susceptible than others.

Source: GrepMed

At almost $90 Billion, the U.S. Weight Loss Industry has reached a historic peak. The rise of prescription drugs such as GLP-1 agonists (Ozempic, Wegovy, Rybelsus, Trulicity, Victoza, and Saxenda; semaglutide, dulaglutide, liraglutide) and combination GIP/GLP-1 agonists (Mounjaro and Zepbound; tirzepatide) has significantly affected the diet industry and revolutionized the treatment of obesity and diabetes. Estimates are that one in eight adults has tried one of these medications for weight loss or to manage diabetes.

How do Ozempic and Simular Drugs Work?

Originally designed as a treatment for diabetes, Ozempic works by mimicking the action of the GLP-1 (glucagon-like peptide-1) hormone, which regulates blood sugar levels and slows down digestion, leading to reduced appetite and, ultimately, weight loss. GLP-1 (incretin hormone) is produced by the gut and increases insulin production from the pancreas only when blood sugar levels are elevated. This targeted action reduces the risk of hypoglycemia (low blood sugar), which is a common concern with other diabetes medications

Ozempic is one of several drugs that have gained immense popularity for their off-label use in weight loss. Weight loss from these drugs is significant and can be up to 15-25% of body weight over the course of 1 – 1.5 years.

  • FDA approved for treating diabetes: Ozempic, Trulicity, and Mounjaro (administered by injection weekly or daily (Victoza).
  • Rybelsus is an oral semaglutide GLP-1 agonist taken daily for diabetes management.
  • FDA approved for weight loss: Wegovy (weekly injection semaglutide) and Saxenda (daily injection liraglutide) are the only GLP-1 medications FDA approved for weight loss. Zepbound (weekly injection tirzepatide) GIP/GLP-1 agonist

** Weight management for obesity (body mass index [BMI] ≥ 30) or overweight (BMI ≥ 27) plus at least one weight-related comorbidity such as hypertension, type 2 diabetes, and high cholesterol.

“Ozempic Face” = Rapid Weight Loss Face

When fat loss occurs in the body, it occurs throughout the body and not in a specific area. This effect is not unique to Ozempic and can be seen with any significant weight loss, especially if it happens quickly. However, because Ozempic is so effective, the facial changes can be more pronounced and have led to the moniker “Ozempic face.” Facial fat changes are more noticeable once patients lose 25 to 30 pounds, but it varies based on the starting weight, height, and facial fat composition.

Fat pads in the face provide structure and volume to the face. Loss of the “youthful” fat creates hollowness around the eyes, cheeks, and temples. This skeletal and aged appearance occurs with normal aging as well. Other factors that increase the chances of developing these facial changes include older age (more common in middle-aged patients and older) and patients with less skin elasticity because of lifestyle (sun damage, smoking), genetics, or skin type. Fair-skinned patients tend to have thinner, less elastic skin and are more susceptible to showing signs of “Ozempic face.”

Can You Treat “Ozempic Face” or Reduce the Risk of It?

To manage the skin and facial changes that occur while taking Ozempic and other weight loss drugs, it is important to see your dermatologist or provider for soft tissue fillers. The ideal time to address facial volume loss is when the patient has achieved their weight loss target. Gradual tapering of weight loss medications can help avoid rebound weight gain once patients stop their medications.

  • Dermal fillers replace the volume loss and can create a fuller, more youthful face. There are several FDA-approved forms of fillers that can be injected into areas such as the cheeks, chin, temples, and under eye area. Seeing a licensed, experienced provider can reduce the risks from dermal fillers which include pain, tenderness, swelling, infection, migration of filler, and more significant complications such as vascular occlusion and tissue necrosis. To replace global facial volume loss, it can take a significant amount of filler. In addition to Hyaluronic Acid fillers (Restalyne, Juvederm), biostimulatory fillers such as poly-L-lactic acid (Sculptra) lead to prolonged effects from collagen production.
  • Skin hydration with medical-grade skin care can promote collagen production, improve skin elasticity, and reduce the appearance of wrinkles. Moisturizers with hyaluronic acid and retinoids can improve skin hydration and texture. Consider estrogen supplements for post-menopausal patients to decrease wrinkles and sagging skin.
  • Autologous fat grafting is a longer-term option that may be performed under location anesthesia.
  • Energy-based skin tightening treatments such as Radiofrequency microneedling, Ulthera, or Softwave are typically beneficial in younger patients with better skin elasticity.
  • Surgical treatment (browlift, blepharoplasty, partial or full facelift, and neck lift) may be needed to address loose skin in older patients or those with more significant facial sagging/aging.
  • Decrease risk of “Ozempic Face” by aiming for gradual weight loss (1-2 pounds per week) which gives the skin more time to adjust to changes. Work with your provider to ensure adequate nutrition – supplement with a multivitamin containing iron and Vitamin D and increase protein content to slow lean body mass loss and reduce the risk of hair loss due to telogen effluvium (hair shedding). Titrate the dose of the medication monthly or as needed. Fullness is felt almost immediately on GLP-1 agonists and most patients report decreased cravings. Increase strength training to maintain basal metabolic rate and lean body mass while on medication.

Conclusion

Obesity treatment and weight loss management are increasingly important today. New medications such as GLP-1 agonists and combination GIP/GLP-1 agonists are incredibly effective medications for the treatment of diabetes and people who are clinically obese. However, “off-label” use has been shown to improve numerous conditions associated with insulin resistance (PCOS), resolve prediabetes, and effectively produce weight loss. For providers who are prescribing these medications, it is important to properly counsel patients to manage their weight loss. Ongoing research, novel triple combination agonist drugs, and oral forms of these powerful weight loss medications offer exciting potential benefits to thousands of patients battling obesity. As with any medication, it is essential to weigh the benefits and potential side effects. Educating patients about potential side effects, including “Ozempic face” will help patients manage distressing changes and allow them to effectively lose weight while maintaining their skin health.

 

 

 

 

 

Further reading:

  1. https://www.americanboardcosmeticsurgery.org/procedure-learning-center/non-surgical/injectable-fillers-guide/
  2. Blackburn GL, Bistrian BR. Hair loss with rapid weight loss. Arch Dermatol. 1977;113(2):234.
  3. Kobren SD. Misuse of Ozempic for Rapid Weight Loss Can Cause Significant and Perhaps Permanent Hair Loss. Derm Times. May 14, 2023.
  4. Busko M. Does Ozempic Cause Hair Loss? Medscape Dermatology. May 25, 2023.
  5. https://www.medscape.com/viewarticle/992377?form=fpf
  6. https://www.msn.com/en-us/health/other/what-is-ozempic-face-4-doctors-explain-the-buzzword-and-the-misconceptions-behind-it/ar-BB1pTwCS
  7. https://www.today.com/health/ozempic-face-rcna67737
  8. Comparing Ozempic, Wegovy and Other GLP-1 Drugs – GoodRx [Internet]. [cited 2023 Apr 24]. https://www.goodrx.com/classes/glp-1-agonists/glp-1-drugs-comparison
  9. Tayag Y. Ozempic Is About to Be Old News [Internet]. The Atlantic. 2023 [cited 2023 Apr 22]. Available from: https://www.theatlantic.com/health/archive/2023/04/ozempic-wegovy-mounjaro-weight-loss-drug-development-access/673627/
  10. LaRose. U.S. Weight Loss Industry Grows to $90 Billion, Fueled by Obesity Drugs Demand. MarketResearch.com
  11. https://blog.marketresearch.com/u.s.-weight-loss-industry-grows-to-90-billion-fueled-by-obesity-drugs-demand
  12. Karam, J. Nathan. A Review of FDA-Approved Medications for Chronic Weight Management. Drug Tropics. Aug 5, 2021.
  13. https://www.drugtopics.com/view/a-review-of-fda-approved-medications-for-chronic-weight-management
  14. Obesity and overweight. CDC. Updated March 1, 2021. Accessed June 24, 2021. https://ww.cdc.gov/nchs/fastats/obesity-overweight.html